Merck & Co., Inc. (MRK) Stock Forecast & Price Target

→ Historic NVIDIA partnership could send this tiny AI stock soaring... (From Behind the Markets) (Ad)

$127.99

+0.49 (+0.38%)

(As of 06/18/2024 ET)

Merck & Co., Inc. - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 13 Analyst Ratings

Consensus Price Target

$133.00
3.91% Upside

High Forecast	$155.00
Average Forecast	$133.00
Low Forecast	$104.00

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	10 Buy rating(s)	16 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$133.00	$131.33	$129.14	$120.75
Forecasted Upside	3.91% Upside	10.85% Upside	10.74% Upside	13.66% Upside

Get Merck & Co., Inc. Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

Ad Behind the Markets

Historic NVIDIA partnership could send this tiny AI stock soaring...

After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next?

Click here to discover the name and ticker symbol >>>

MRK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MRK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Merck & Co., Inc. Stock vs. The Competition

Type	Merck & Co., Inc.	Medical Companies	S&P 500
Consensus Rating Score	2.69	2.70	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	3.91% Upside	1,068.20% Upside	11.31% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$155.00 ➝ $155.00	+21.55%
6/5/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Hellweg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/26/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$142.00 ➝ $143.00	+8.80%
4/8/2024	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$140.00 ➝ $143.00	+11.73%
3/27/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$130.00 ➝ $135.00	+7.54%
3/11/2024	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Sell	$104.00	-15.33%
Get the Latest News and Ratings for MRK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Merck & Co., Inc. and its competitors with MarketBeat's FREE daily newsletter.
2/2/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$135.00 ➝ $148.00	+16.95%
2/2/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$135.00 ➝ $145.00	+14.70%
1/4/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$125.00 ➝ $135.00	+17.63%
11/9/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$115.00	+10.15%
10/27/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $118.00	+12.19%
10/27/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$132.00	+25.04%
7/14/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$123.00	+15.70%
4/16/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
4/13/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$105.00 ➝ $130.00	+14.29%
4/11/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$123.00 ➝ $124.00	+10.11%
4/10/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mara Goldstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$130.00	+15.44%
3/7/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$122.00 ➝ $127.00	+14.14%
3/7/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$125.00 ➝ $126.00	+13.24%
3/6/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$125.00	+16.95%
2/23/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$120.00 ➝ $125.00	+13.08%
2/22/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Peer Perform ➝ Outperform	$127.00	+16.44%
2/3/2023	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$120.00 ➝ $122.00	+17.92%
1/4/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$110.00 ➝ $130.00	+16.97%
1/3/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$108.00 ➝ $120.00	+8.16%
8/25/2022	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
7/6/2022	Daiwa Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$89.00 ➝ $102.00	+10.10%
6/27/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform	$95.00 ➝ $102.00	+9.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:08 AM ET.

MRK Forecast - Frequently Asked Questions

What is Merck & Co., Inc.'s stock forecast and purchase recommendation?: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Merck & Co., Inc. is $133.00, with a high forecast of $155.00 and a low forecast of $104.00. The consensus rating for Merck & Co., Inc. stock is Moderate Buy based on the current 1 sell rating, 3 hold ratings, 8 buy ratings and 1 strong buy rating for MRK. Learn more on MRK's analyst rating history.
Do Wall Street analysts like Merck & Co., Inc. more than its competitors?: Analysts like Merck & Co., Inc. less than other "medical" companies. The consensus rating score for Merck & Co., Inc. is 2.69 while the average consensus rating score for "medical" companies is 2.70. Learn more on how MRK compares to other companies.
Is Merck & Co., Inc. being upgraded by Wall Street analysts?: Over the previous 90 days, Merck & Co., Inc.'s stock had 1 upgrade by analysts.

Does Merck & Co., Inc.'s stock price have much upside?: According to analysts, Merck & Co., Inc.'s stock has a predicted upside of 12.04% based on their 12-month stock forecasts.
What analysts cover Merck & Co., Inc.?: Merck & Co., Inc. has been rated by research analysts at Argus, Berenberg Bank, Cantor Fitzgerald, Truist Financial, and Wells Fargo & Company in the past 90 days.